Enanta Pharmaceuticals Inc

8-K

Enanta Pharmaceuticals announced positive Phase 2b data for zelicapavir in high-risk adults with RSV, showing improved outcomes. The study included 186 subjects, with a 1.7% hospitalization rate for zelicapavir compared to 5% for placebo.

Enanta Pharmaceuticals Inc ENTA is headquartered in Watertown, MA.

Source

Posted Sep 29, 2025, 11:33 AM UTC